Kaiser Aluminum Announces Third Quarter 2016 Earnings Release and Conference Call
Oct 04, 2016 20:30 pm UTC| Business
FOOTHILL RANCH, Calif., Oct. 04, 2016 -- Kaiser Aluminum Corporation (NASDAQ:KALU) today announced that it plans to release its third quarter 2016 financial and operating results on Wednesday, October 19, 2016, after...
Top Ships Inc. announces the results of its 2016 annual meeting of shareholders
Oct 04, 2016 20:30 pm UTC| Business
ATHENS, Greece, Oct. 04, 2016 -- TOP Ships Inc. (Nasdaq:TOPS), an international ship-owning company (the “Company”), announced today the results of its 2016 annual meeting of shareholders. Specifically: Alexandros...
Oxford Immunotec Announces Closing of $40 Million in Debt Financing
Oct 04, 2016 20:24 pm UTC| Business
OXFORD, United Kingdom and MARLBOROUGH, Mass., Oct. 04, 2016 -- Oxford Immunotec Global PLC(Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the...
Ocwen and NID Join Forces with NAACP to Assist Struggling Homeowners in Sacramento, California
Oct 04, 2016 20:20 pm UTC| Business
WEST PALM BEACH, Fla., Oct. 04, 2016 -- Ocwen Financial Corporation (NYSE:OCN), a leading financial services holding company, and NID Housing Counseling Agency (NID), a U.S. Department of Housing and Urban Development...
WhiteWave Stockholders Approve Merger with Danone
Oct 04, 2016 20:20 pm UTC| Business
DENVER, Oct. 04, 2016 -- The WhiteWave Foods Company (NYSE:WWAV) (“WhiteWave”), a leading consumer packaged food and beverage company in North America and Europe, announced that during a special stockholder meeting...
Oct 04, 2016 20:20 pm UTC| Business
MOORESTOWN, N.J., Oct. 04, 2016 -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication...
REGENXBIO to Present at the Jefferies Gene Editing and Gene Therapy Summit
Oct 04, 2016 20:16 pm UTC| Business
ROCKVILLE, Md., Oct. 04, 2016 -- REGENXBIO Inc. (Nasdaq:RGNX), a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno-associated virus (AAV) gene therapy based...